Cart
0

Smart Pills Market by Application (Capsule Endoscopy, Patient Monitoring, and Drug Delivery), Target Area (Stomach, Esophagus, Small Intestine, and Large Intestine), Disease Indication (Esophageal Diseases, Small bowel Diseases, Colon Diseases, and Others), and End User (Hospital, Diagnostic Center, and Research Center): Global Opportunity Analysis and Industry Forecast, 2018 - 2025

Get 20% Free Customization In This Report
LI_181138
Pages: 228
Sep 2018 | 1251 Views
 
Author's : Kavita Joshi, Tanvi Sapatnekar & Onkar Sumant
Tables: 146
Charts: 39
 

Smart Pills Market Overview:

Smart pills are capsule-sized ingestible medical devices consisting of elements such as sensors, cameras, patches, and trackers that help in better diagnostics, patient monitoring, as well as targeted drug delivery. They are majorly available in the form of a vitamin capsule sized pill and possess small wearable sensor patch, an application on a mobile device, and a provider portal. Once swallowed, it gets activated in the gut; the sensors provide information about patient’s health parameters and the effectiveness of medication treatment leading to more informed healthcare decisions and optimized therapies. Moreover, smart pills have revolutionized the field of gastrointestinal diagnosis. Smart pills, being non-invasive can be a potent alternative approach against invasive procedures such as gastrointestinal endoscopy/colonoscopy. The global smart pills market was valued at $257 million in 2017, and is expected to reach $650 million by 2025, registering a CAGR of 12.1% from 2018 to 2025.

Smart Pills Market
Get more information on this report: Request Sample Pages

A considerable increase in geriatric population, rise in chronic disorders such as cancer, diabetes, and others, and surge in prevalence of lifestyle-related disorders, such as obesity, gastroesophageal reflux disease (GERD), gastric ulcers, and others majorly drive the growth of the smart pills market. In addition, increased R&D investments in developing smart pills further boost the market growth. However, stringent government regulations regarding the increased use of these devices and high cost associated with the ingestible sensors are the factors anticipated to restrain the growth of the market. Furthermore, rise in technological advances pertaining to smart pills such as bioelectronics, availability of microprocessors, micro-cameras, miniaturization, and others are predicted to offer lucrative opportunities in future.

Smart Pills Market By Application

Get more information on this report: Request Sample Pages

Application segment review

Based on application, the smart pills market is bifurcated into capsule endoscopy, drug delivery, and patient monitoring. The capsule endoscopy application segment was the highest contributor to the market, in 2017, and is anticipated to maintain its dominance throughout the forecast period. This is attributed to the increase in preferences toward non-invasive diagnostic procedures and the significant increase in gastrointestinal disorders across the globe.

Smart Pills Market By Target Area

Get more information on this report: Request Sample Pages

Target Area segment review

Based on the target area, the smart pills market is classified into the esophagus, small intestine, large intestine, and stomach. The small intestine target area accounted for the highest revenue in 2017 and is expected to maintain its dominance throughout the forecast period. This is attributed to the significant increase in small intestinal disorders such as Crohn’s disease, celiac disease, and small bowel tumors.

Smart Pills Market By Region

Get more information on this report: Request Sample Pages

Geography segment review

Based on region, the smart pill market is analyzed across North America, Europe, Asia-Pacific, and LAMEA. North America dominated the market in 2017, accounting for highest share, and is anticipated to maintain this trend throughout the forecast period. However, Asia-Pacific is projected to register the highest growth rate from 2018 to 2025. 

The report provides a comprehensive analysis of the leading companies operating in the global market such as Proteus Digital Health, HQ, Inc., CapsoVision, Inc., Medtronic Plc., Olympus Corporations, IntroMedic Co., Ltd, RF Co., Ltd, JINSHAN Science & Technology, Check-Cap, and Koninklijke Philips N.V. The other key players in the value chain (not included in the report) include GE Healthcare, NOVARTIS AG, Fujifilm Holdings Corporation, Bio-Images Drug Delivery (BDD) Limited, Quotient Clinical Ltd., Innovative Devices LLC, and PENTAX Medical

Key Benefits for the Smart Pills Market:

  • The study provides an in-depth analysis of the smart pills market with the current trends and future estimations to elucidate the imminent investment pockets.

  • Comprehensive analysis of the factors that drive and restrict the market growth is provided.

  • Comprehensive quantitative analysis of the industry is provided from 2018 to 2025 to assist stakeholders to capitalize on the prevailing market opportunities.

  • Extensive analysis of the key segments of the industry helps to understand the trends in smart pills market globally.

  • Key players and their strategies are provided to understand the competitive outlook of the industry.

Smart Pills Market Key Segments

By Application

  • Capsule Endoscopy
  • Drug Delivery
  • Patient Monitoring

By Target Area

  • Esophagus
  • Small Intestine
  • Large Intestine
  • Stomach

By Disease Indication

  • Esophageal Diseases
  • Small Bowel Diseases 
  • Colon Diseases
  • Others

By End User

  • Hospital
  • Diagnostic Center
  • Research Institute

By Region

  • North America

    • US
    • Canada
    • Mexico
  • Europe

    • UK
    • France
    • Germany
    • Italy
    • France
    • Russia
    • Rest of Europe
  • Asia-Pacific

    • Japan
    • China
    • India
    • South Korea
    • Taiwan
    • Australia
    • Rest of Asia-Pacific
  • LAMEA 

    • Saudi Arabia
    • South Africa
    • Brazil
    • Argentina
    • Rest of LAMEA
 

Chapter: 1: INTRODUCTION

1.1. Report description
1.2. Key benefits for stakeholders
1.3. Key market segments
1.4. Research methodology

1.4.1. Secondary research
1.4.2. Primary research
1.4.3. Analyst tools & models

Chapter: 2: EXECUTIVE SUMMARY

2.1. CXO perspective

Chapter: 3: MARKET OVERVIEW

3.1. Market definition and scope
3.2. Key findings

3.2.1. Top investment pockets
3.2.2. Top Winning Strategies

3.3. Porters five forces analysis
3.4. Market share analysis
3.5. Market dynamics

3.5.1. Drivers

3.5.1.1. Rising prevalence of gastrointestinal disorders
3.5.1.2. Increase in the R&D investments in developing smart pills by manufacturers

3.5.2. Restraints

3.5.2.1. Lengthy timelines regarding approval of smart pills
3.5.2.2. Higher costs associated with the smart pills

3.5.3. Opportunity

3.5.3.1. Increase in the technological advancements pertaining to smart pills

Chapter: 4: SMART PILLS MARKET, BY APPLICATION

4.1. Overview

4.1.1. Market size and forecast

4.2. Capsule Endoscopy

4.2.1. Key trends and opportunities
4.2.2. Market size and forecast
4.2.3. Market analysis, by country

4.3. Drug Delivery

4.3.1. Key trends and opportunities
4.3.2. Market size and forecast
4.3.3. Market analysis, by country

4.4. Patient Monitoring

4.4.1. Key trends and opportunities
4.4.2. Market size and forecast
4.4.3. Market analysis, by country

Chapter: 5: SMART PILLS MARKET, BY TARGET AREA

5.1. Overview

5.1.1. Market size and forecast

5.2. Esophagus

5.2.1. Market size and forecast
5.2.2. Market analysis, by country

5.3. Stomach

5.3.1. Market size and forecast
5.3.2. Market analysis, by country

5.4. Small Intestine

5.4.1. Market size and forecast
5.4.2. Market analysis, by country

5.5. Large Intestine

5.5.1. Market size and forecast
5.5.2. Market analysis, by country

Chapter: 6: SMART PILLS MARKET, BY DISEASE INDICATION

6.1. Overview

6.1.1. Market size and forecast

6.2. Esophagus Diseases

6.2.1. Market size and forecast
6.2.2. Market analysis, by country

6.3. Small Bowel Disease

6.3.1. Market size and forecast
6.3.2. Market analysis, by country

6.3.2.1. Crohns Disease

6.3.2.1.1. Market size and forecast

6.3.2.2. Small bowel tumors

6.3.2.2.1. Market size and forecast

6.3.2.3. Celiac disease

6.3.2.3.1. Market size and forecast

6.3.2.4. Others

6.3.2.4.1. Market size and forecast

6.4. Colon Diseases

6.4.1. Market size and forecast
6.4.2. Market analysis, by country

Chapter: 7: SMART PILLS MARKET, BY END USER

7.1. Overview

7.1.1. Market size and forecast

7.2. Diagnostic Centers

7.2.1. Market size and forecast
7.2.2. Market analysis, by country

7.3. Hospitals & Clinics

7.3.1. Market size and forecast
7.3.2. Market analysis, by country

7.4. Research Institutes

7.4.1. Market size and forecast
7.4.2. Market analysis, by country

Chapter: 8: SMART PILLS MARKET, BY REGION

8.1. Overview

8.1.1. Market size and forecast

8.2. North America

8.2.1. North America market size & forecast, by country
8.2.2. North America market size & forecast, by application
8.2.3. North America market size & forecast, by target area
8.2.4. North America market size & forecast, by disease indication
8.2.5. North America market size & forecast, by end user

8.2.5.1. U.S. market size & forecast, by application
8.2.5.2. U.S. market size & forecast, by target area
8.2.5.3. U.S. market size & forecast, by disease indication
8.2.5.4. U.S. market size & forecast, by end user
8.2.5.5. Canada market size & forecast, by application
8.2.5.6. Canada market size & forecast, by target area
8.2.5.7. Canada market size & forecast, by disease indication
8.2.5.8. Canada market size & forecast, by end user
8.2.5.9. Mexico market size & forecast, by application
8.2.5.10. Mexico market size & forecast, by target area
8.2.5.11. Mexico market size & forecast, by disease indication
8.2.5.12. Mexico market size & forecast, by end user

8.3. Europe

8.3.1. Key trends and opportunities
8.3.2. Europe market size & forecast for smart pills market, by country
8.3.3. Europe market size & forecast, by application
8.3.4. Europe market size & forecast, by target area
8.3.5. Europe market size & forecast, by disease indication
8.3.6. Europe market size & forecast, by end user

8.3.6.1. Germany market size & forecast, by application
8.3.6.2. Germany market size & forecast, by target area
8.3.6.3. Germany market size & forecast, by disease indication
8.3.6.4. Germany market size & forecast, by end user
8.3.6.5. France market size & forecast, by application
8.3.6.6. France market size & forecast, by target area
8.3.6.7. France market size & forecast, by disease indication
8.3.6.8. France market size & forecast, by end user
8.3.6.9. UK market size & forecast, by application
8.3.6.10. UK market size & forecast, by target area
8.3.6.11. UK market size & forecast, by disease indication
8.3.6.12. UK market size & forecast, by end user
8.3.6.13. Italy market size & forecast, by application
8.3.6.14. Italy market size & forecast, by target area
8.3.6.15. Italy market size & forecast, by disease indication
8.3.6.16. Italy market size & forecast, by end user
8.3.6.17. Spain market size & forecast, by application
8.3.6.18. Spain market size & forecast, by target area
8.3.6.19. Spain market size & forecast, by disease indication
8.3.6.20. Spain market size & forecast, by end user
8.3.6.21. Rest of Europe market size & forecast, by application
8.3.6.22. Rest of Europe market size & forecast, by target area
8.3.6.23. Rest of Europe market size & forecast, by disease indication
8.3.6.24. Rest of Europe market size & forecast, by end user

8.4. Asia-Pacific

8.4.1. Key trends and opportunities
8.4.2. Asia-Pacific market size & forecast, by country
8.4.3. Asia-Pacific market size & forecast, by application
8.4.4. Asia-Pacific market size & forecast, by target area
8.4.5. Asia-Pacific market size & forecast, by disease indication
8.4.6. Asia-Pacific market size & forecast, by end user

8.4.6.1. India market size & forecast, by application
8.4.6.2. India market size & forecast, by target area
8.4.6.3. India market size & forecast, by disease indication
8.4.6.4. India market size & forecast, by end user
8.4.6.5. China market size & forecast, by application
8.4.6.6. China market size & forecast, by target area
8.4.6.7. China market size & forecast, by disease indication
8.4.6.8. China market size & forecast, by end user
8.4.6.9. Japan market size & forecast, by application
8.4.6.10. Japan market size & forecast, by target area
8.4.6.11. Japan market size & forecast, by disease indication
8.4.6.12. India market size & forecast, by end user
8.4.6.13. Australia market size & forecast, by application
8.4.6.14. Australia market size & forecast, by target area
8.4.6.15. Australia market size & forecast, by disease indication
8.4.6.16. Australia market size & forecast, by end user
8.4.6.17. Rest of Asia-Pacific market size & forecast, by application
8.4.6.18. Rest of Asia-Pacific market size & forecast, by Target Area
8.4.6.19. Rest of Asia-Pacific market size & forecast, by disease indication
8.4.6.20. Rest of Asia-Pacific market size & forecast, by end user

8.5. LAMEA

8.5.1. Key trends and opportunities
8.5.2. LAMEA market size & forecast, by country
8.5.3. LAMEA market size & forecast, by application
8.5.4. LAMEA market size & forecast, by target area
8.5.5. LAMEA market size & forecast, by disease indication
8.5.6. LAMEA market size & forecast, by end user

8.5.6.1. Brazil market size & forecast, by application
8.5.6.2. Brazil market size & forecast, by target area
8.5.6.3. Brazil market size & forecast, by disease indication
8.5.6.4. Brazil market size & forecast, by end user
8.5.6.5. South Africa market size & forecast, by application
8.5.6.6. South Africa market size & forecast, by target area
8.5.6.7. South Africa market size & forecast, by disease indication
8.5.6.8. South Africa market size & forecast, by end user
8.5.6.9. Saudi Arabia market size & forecast, by application
8.5.6.10. Saudi Arabia market size & forecast, by target area
8.5.6.11. Saudi Arabia market size & forecast, by disease indication
8.5.6.12. Saudi Arabia market size & forecast, by end user
8.5.6.13. Argentina market size & forecast, by application
8.5.6.14. Argentina market size & forecast, by target area
8.5.6.15. Argentina market size & forecast, by disease indication
8.5.6.16. Argentina market size & forecast, by end user
8.5.6.17. Rest of LAMEA market size & forecast, by application
8.5.6.18. Rest of LAMEA market size & forecast, by target area
8.5.6.19. Rest of LAMEA market size & forecast, by disease indication
8.5.6.20. Rest of LAMEA market size & forecast, by end user

Chapter: 9: COMPANY PROFILES

9.1. CapsoVision, Inc.

9.1.1. Company overview
9.1.2. Company snapshot
9.1.3. Operating business segments
9.1.4. Product portfolio
9.1.5. Key strategic moves and developments

9.2. Check-Cap Ltd.

9.2.1. Company overview
9.2.2. Company snapshot
9.2.3. Operating business segments
9.2.4. Product portfolio

9.3. HQ.Inc.

9.3.1. Company overview
9.3.2. Company snapshot
9.3.3. Operating business segments
9.3.4. Product portfolio

9.4. IntroMedic Co., Ltd

9.4.1. Company overview
9.4.2. Company snapshot
9.4.3. Operating business segments
9.4.4. Product portfolio
9.4.5. Business performance
9.4.6. Key strategic moves and developments

9.5. JINSHAN Science & Technology

9.5.1. Company overview
9.5.2. Company snapshot
9.5.3. Operating business segments
9.5.4. Product portfolio
9.5.5. Key strategic moves and developments

9.6. Koninklijke Philips N.V.

9.6.1. Company overview
9.6.2. Company snapshot
9.6.3. Operating business segments
9.6.4. Product portfolio
9.6.5. Business performance

9.7. Medtronic plc

9.7.1. Company overview
9.7.2. Company snapshot
9.7.3. Operating business segments
9.7.4. Product portfolio
9.7.5. Business performance
9.7.6. Key strategic moves and developments

9.8. OLYMPUS Corporation.

9.8.1. Company overview
9.8.2. Company snapshot
9.8.3. Operating business segments
9.8.4. Product portfolio
9.8.5. Business performance

9.9. Proteus Digital Health

9.9.1. Company overview
9.9.2. Company snapshot
9.9.3. Operating business segments
9.9.4. Product portfolio
9.9.5. Key strategic moves and developments

9.10. RF Co., Ltd.

9.10.1. Company overview
9.10.2. Company snapshot
9.10.3. Operating business segments
9.10.4. Product portfolio

LIST OF TABLES

TABLE 01. GLOBAL SMART PILLS MARKET, BY APPLICATION 2017-2025 ($MILLION)
TABLE 02. CAPSULE ENDOSCOPE AVAILABLE IN THE MARKET
TABLE 03. GLOBAL SMART PILLS MARKET FOR CAPSULE ENDOSCOPY, BY REGION, 2017-2025 ($MILLION)
TABLE 04. SMART CAPSULE FOR DRUG DELIVERY AVAILABLE IN THE MARKET
TABLE 05. SMART PILLS MARKET FOR DRUG DELIVERY, BY REGION, 2017-2025 ($MILLION)
TABLE 06. SMART CAPSULE FOR PATIENT MONITORING AVAILABLE IN THE MARKET
TABLE 07. SMART PILLS MARKET FOR PATIENT MONITORING, BY REGION, 2017-2025 ($MILLION)
TABLE 08. GLOBAL SMART PILLS MARKET, BY TARGET AREA, 2017-2025 ($MILLION)
TABLE 09. SMART PILLS MARKET, FOR ESOPHAGUS, BY REGION, 2017-2025 ($MILLION)
TABLE 10. SMART PILLS MARKET, FOR STOMACH, BY REGION, 2017-2025 ($MILLION)
TABLE 11. SMART PILLS MARKET, FOR SMALL INTESTINE, BY REGION, 2017-2025 ($MILLION)
TABLE 12. SMART PILLS MARKET, FOR LARGE INTESTINE, BY REGION, 2017-2025 ($MILLION)
TABLE 13. GLOBAL SMART PILLS MARKET, BY DISEASE INDICATION, 2017-2025 ($MILLION)
TABLE 14. SMART PILLS MARKET, FOR ESOPHAGUS DISEASES, BY REGION, 2017-2025 ($MILLION)
TABLE 15. SMART PILL MARKET, FOR SMALL BOWEL DISEASES, BY REGION, 2017-2025 ($MILLION)
TABLE 16. SMART PILL MARKET, FOR COLON DISEASES, BY REGION, 2017-2025 ($MILLION)
TABLE 17. GLOBAL SMART PILLS MARKET, BY END USER, 2017-2025 ($MILLION)
TABLE 18. SMART PILLS MARKET FOR DIAGNOSTIC CENTRES, BY REGION, 2017-2025 ($MILLION)
TABLE 19. GLOBAL SMART PILLS MARKET FOR HOSPITALS, BY REGION, 2017-2025 ($MILLION)
TABLE 20. SMART PILLS MARKET FOR RESEARCH INSTITUTES, BY REGION, 2017-2025 ($MILLION)
TABLE 21. SMART PILLS MARKET, BY REGION, 2017-2025 ($MILLION)
TABLE 22. NORTH AMERICA SMART PILLS MARKET, BY COUNTRY, 2017-2025 ($MILLION)
TABLE 23. NORTH AMERICA SMART PILLS MARKET, BY APPLICATION, 2017-2025 ($MILLION)
TABLE 24. NORTH AMERICA SMART PILLS MARKET, BY TARGET AREA, 2017-2025 ($MILLION)
TABLE 25. NORTH AMERICA SMART PILLS MARKET, BY DISEASE INDICATION, 2017-2025 ($MILLION)
TABLE 26. NORTH AMERICA SMART PILLS MARKET, BY END USER, 2017-2025 ($MILLION)
TABLE 27. U.S. SMART PILLS MARKET, BY APPLICATION, 2017-2025 ($MILLION)
TABLE 28. U.S. SMART PILLS MARKET, BY TARGET AREA, 2017-2025 ($MILLION)
TABLE 29. U.S. SMART PILLS MARKET, BY DISEASE INDICATION, 2017-2025 ($MILLION)
TABLE 30. U.S. SMART PILLS MARKET, BY END USER, 2017-2025 ($MILLION)
TABLE 31. CANADA SMART PILLS MARKET, BY APPLICATION, 2017-2025 ($MILLION)
TABLE 32. CANADA SMART PILLS MARKET, BY TARGET AREA, 2017-2025 ($MILLION)
TABLE 33. CANADA SMART PILLS MARKET, BY DISEASE INDICATION, 2017-2025 ($MILLION)
TABLE 34. CANADA SMART PILLS MARKET, BY END USER, 2017-2025 ($MILLION)
TABLE 35. MEXICO SMART PILLS MARKET, BY APPLICATION, 2017-2025 ($MILLION)
TABLE 36. MEXICO SMART PILLS MARKET, BY TARGET AREA, 2017-2025 ($MILLION)
TABLE 37. MEXICO SMART PILLS MARKET, BY DISEASE INDICATION, 2017-2025 ($MILLION)
TABLE 38. MEXICO SMART PILLS MARKET, BY END USER, 2017-2025 ($MILLION)
TABLE 39. EUROPE SMART PILLS MARKET, BY COUNTRY, 2017-2025 ($MILLION)
TABLE 40. EUROPE SMART PILLS MARKET, BY APPLICATION, 2017-2025 ($MILLION)
TABLE 41. EUROPE SMART PILLS MARKET, BY TARGET AREA, 2017-2025 ($MILLION)
TABLE 42. EUROPE SMART PILLS MARKET, BY DISEASE INDICATION, 2017-2025 ($MILLION)
TABLE 43. EUROPE SMART PILLS MARKET, BY END USER, 2017-2025 ($MILLION)
TABLE 44. GERMANY SMART PILLS MARKET, BY APPLICATION, 2017-2025 ($MILLION)
TABLE 45. GERMANY SMART PILLS MARKET, BY TARGET AREA, 2017-2025 ($MILLION)
TABLE 46. GERMANY SMART PILLS MARKET, BY DISEASE INDICATION, 2017-2025 ($MILLION)
TABLE 47. GERMANY SMART PILLS MARKET, BY END USER, 2017-2025 ($MILLION)
TABLE 48. FRANCE SMART PILLS MARKET, BY APPLICATION, 2017-2025 ($MILLION)
TABLE 49. FRANCE SMART PILLS MARKET, BY TARGET AREA, 2017-2025 ($MILLION)
TABLE 50. FRANCE SMART PILLS MARKET, BY DISEASE INDICATION, 2017-2025 ($MILLION)
TABLE 51. FRANCE SMART PILLS MARKET, BY END USER, 2017-2025 ($MILLION)
TABLE 52. UK SMART PILLS MARKET, BY APPLICATION, 2017-2025 ($MILLION)
TABLE 53. UK SMART PILLS MARKET, BY TARGET AREA, 2017-2025 ($MILLION)
TABLE 54. UK SMART PILLS MARKET, BY DISEASE INDICATION, 2017-2025 ($MILLION)
TABLE 55. UK SMART PILLS MARKET, BY END USER, 2017-2025 ($MILLION)
TABLE 56. ITALY SMART PILLS MARKET, BY APPLICATION, 2017-2025 ($MILLION)
TABLE 57. ITALY SMART PILLS MARKET, BY TARGET AREA, 2017-2025 ($MILLION)
TABLE 58. ITALY SMART PILLS MARKET, BY DISEASE INDICATION, 2017-2025 ($MILLION)
TABLE 59. ITALY SMART PILLS MARKET, BY END USER, 2017-2025 ($MILLION)
TABLE 60. SPAIN SMART PILLS MARKET, BY APPLICATION, 2017-2025 ($MILLION)
TABLE 61. SPAIN SMART PILLS MARKET, BY TARGET AREA, 2017-2025 ($MILLION)
TABLE 62. SPAIN SMART PILLS MARKET, BY DISEASE INDICATION, 2017-2025 ($MILLION)
TABLE 63. SPAIN SMART PILLS MARKET, BY END USER, 20172025 ($MILLION)
TABLE 64. REST OF EUROPE SMART PILLS MARKET, BY APPLICATION, 2017-2025 ($MILLION)
TABLE 65. REST OF EUROPE SMART PILLS MARKET, BY TARGET AREA, 2017-2025 ($MILLION)
TABLE 66. REST OF EUROPE SMART PILLS MARKET, BY DISEASE INDICATION, 2017-2025 ($MILLION)
TABLE 67. REST OF EUROPE SMART PILLS MARKET, BY END USER, 2017-2025 ($MILLION)
TABLE 68. ASIA-PACIFIC SMART PILLS MARKET, BY COUNTRY, 2017-2025 ($MILLION)
TABLE 69. ASIA-PACIFIC SMART PILLS MARKET, BY APPLICATION, 2017-2025 ($MILLION)
TABLE 70. ASIA-PACIFIC SMART PILLS MARKET, BY TARGET AREA, 2017-2025 ($MILLION)
TABLE 71. ASIA-PACIFIC SMART PILLS MARKET, BY DISEASE INDICATION, 2017-2025 ($MILLION)
TABLE 72. ASIA-PACIFIC SMART PILLS MARKET, BY END USER, 2017-2025 ($MILLION)
TABLE 73. INDIA SMART PILLS MARKET, BY APPLICATION, 2017-2025 ($MILLION)
TABLE 74. INDIA SMART PILLS MARKET, BY TARGET AREA, 2017-2025 ($MILLION)
TABLE 75. INDIA SMART PILLS MARKET, BY DISEASE INDICATION, 2017-2025 ($MILLION)
TABLE 76. INDIA SMART PILLS MARKET, BY END USER, 2017-2025 ($MILLION)
TABLE 77. CHINA SMART PILLS MARKET, BY APPLICATION, 2017-2025 ($MILLION)
TABLE 78. CHINA SMART PILLS MARKET, BY TARGET AREA, 2017-2025 ($MILLION)
TABLE 79. CHINA SMART PILLS MARKET, BY DISEASE INDICATION, 2017-2025 ($MILLION)
TABLE 80. CHINA SMART PILLS MARKET, BY END USER, 2017-2025 ($MILLION)
TABLE 81. JAPAN SMART PILLS MARKET, BY APPLICATION, 2017-2025 ($MILLION)
TABLE 82. JAPAN SMART PILLS MARKET, BY TARGET AREA, 2017-2025 ($MILLION)
TABLE 83. JAPAN SMART PILLS MARKET, BY DISEASE INDICATION, 2017-2025 ($MILLION)
TABLE 84. INDIA SMART PILLS MARKET, BY END USER, 2017-2025 ($MILLION)
TABLE 85. AUSTRALIA SMART PILLS MARKET, BY APPLICATION, 2017-2025 ($MILLION)
TABLE 86. AUSTRALIA SMART PILLS MARKET, BY TARGET AREA, 2017-2025 ($MILLION)
TABLE 87. AUSTRALIA SMART PILLS MARKET, BY DISEASE INDICATION, 2017-2025 ($MILLION)
TABLE 88. AUSTRALIA SMART PILLS MARKET, BY END USER, 2017-2025 ($MILLION)
TABLE 89. REST OF ASIA-PACIFIC SMART PILLS MARKET, BY APPLICATION, 2017-2025 ($MILLION)
TABLE 90. REST OF ASIA-PACIFIC SMART PILLS MARKET, BY TARGET AREA, 2017-2025 ($MILLION)
TABLE 91. REST OF ASIA-PACIFIC SMART PILLS MARKET, BY DISEASE INDICATION, 2017-2025 ($MILLION)
TABLE 92. REST OF ASIA-PACIFIC SMART PILLS MARKET, BY END USER, 2017-2025 ($MILLION)
TABLE 93. LAMEA SMART PILLS MARKET, BY COUNTRY, 2017-2025 ($MILLION)
TABLE 94. LAMEA SMART PILLS MARKET, BY APPLICATION, 2017-2025 ($MILLION)
TABLE 95. LAMEA SMART PILLS MARKET, BY TARGET AREA, 2017-2025 ($MILLION)
TABLE 96. LAMEA SMART PILLS MARKET, BY DISEASE INDICATION, 2017-2025 ($MILLION)
TABLE 97. LAMEA SMART PILLS MARKET, BY END USER, 2017-2025 ($MILLION)
TABLE 98. BRAZIL SMART PILLS MARKET, BY APPLICATION, 2017-2025 ($MILLION)
TABLE 99. BRAZIL SMART PILLS MARKET, BY TARGET AREA, 2017-2025 ($MILLION)
TABLE 100. BRAZIL SMART PILLS MARKET, BY DISEASE INDICATION, 2017-2025 ($MILLION)
TABLE 101. BRAZIL SMART PILLS MARKET, BY END USER, 2017-2025 ($MILLION)
TABLE 102. SOUTH AFRICA SMART PILLS MARKET, BY APPLICATION, 2017-2025 ($MILLION)
TABLE 103. SOUTH AFRICA SMART PILLS MARKET, BY TARGET AREA, 2017-2025 ($MILLION)
TABLE 104. SOUTH AFRICA SMART PILLS MARKET, BY DISEASE INDICATION, 2017-2025 ($MILLION)
TABLE 105. SOUTH AFRICA SMART PILLS MARKET, BY END USER, 2017-2025 ($MILLION)
TABLE 106. SAUDI ARABIA SMART PILLS MARKET, BY APPLICATION, 2017-2025 ($MILLION)
TABLE 107. SAUDI ARABIA SMART PILLS MARKET, BY TARGET AREA, 2017-2025 ($MILLION)
TABLE 108. SAUDI ARABIA SMART PILLS MARKET, BY DISEASE INDICATION, 2017-2025 ($MILLION)
TABLE 109. SAUDI ARABIA SMART PILLS MARKET, BY END USER, 2017-2025 ($MILLION)
TABLE 110. ARGENTINA SMART PILLS MARKET, BY APPLICATION, 2017-2025 ($MILLION)
TABLE 111. ARGENTINA SMART PILLS MARKET, BY TARGET AREA, 2017-2025 ($MILLION)
TABLE 112. ARGENTINA SMART PILLS MARKET, BY DISEASE INDICATION, 2017-2025 ($MILLION)
TABLE 113. ARGENTINA SMART PILLS MARKET, BY END USER, 2017-2025 ($MILLION)
TABLE 114. REST OF LAMEA SMART PILLS MARKET, BY APPLICATION, 2017-2025 ($MILLION)
TABLE 115. REST OF LAMEA SMART PILLS MARKET, BY TARGET AREA, 2017-2025 ($MILLION)
TABLE 116. REST OF LAMEA SMART PILLS MARKET, BY DISEASE INDICATION, 2017-2025 ($MILLION)
TABLE 117. REST OF LAMEA SMART PILLS MARKET, BY END USER, 2017-2025 ($MILLION)
TABLE 118. CAPSOVISION: COMPANY SNAPSHOT
TABLE 119. CAPSOVISION: OPERATING SEGMENTS
TABLE 120. CAPSOVISION: PRODUCT PORTFOLIO
TABLE 121. CHECK- CAP: COMPANY SNAPSHOT
TABLE 122. CHECK-CAP OPERATING SEGMENTS
TABLE 123. CHECK-CAP PRODUCT PORTFOLIO
TABLE 124. HQ. COMPANY SNAPSHOT
TABLE 125. HQ.: OPERATING SEGMENTS
TABLE 126. HQ.: PRODUCT PORTFOLIO
TABLE 127. INTROMEDIC: COMPANY SNAPSHOT
TABLE 128. INTROMEDIC: PRODUCT PORTFOLIO
TABLE 129. JINSHAN: COMPANY SNAPSHOT
TABLE 130. JINSHAN: PRODUCT SEGMENTS
TABLE 131. JINSHAN: PRODUCT PORTFOLIO
TABLE 132. PHILIPS: COMPANY SNAPSHOT
TABLE 133. PHILIPS: OPERATING SEGMENTS
TABLE 134. PHILIPS: PRODUCT PORTFOLIO
TABLE 135. MEDTRONIC: COMPANY SNAPSHOT
TABLE 136. MEDTRONIC: OPERATING SEGMENTS
TABLE 137. MEDTRONIC: PRODUCT PORTFOLIO
TABLE 138. OLYMPUS: COMPANY SNAPSHOT
TABLE 139. OLYMPUS: OPERATING SEGMENTS
TABLE 140. OLYMPUS: PRODUCT PORTFOLIO
TABLE 141. PROTEUS: COMPANY SNAPSHOT
TABLE 142. PROTEUS: OPERATING SEGMENTS
TABLE 143. PROTEUS: PRODUCT PORTFOLIO
TABLE 144. RF CO., LTD: COMPANY SNAPSHOT
TABLE 145. RF : PRODUCT SEGMENTS
TABLE 146. RF CO.: PRODUCT PORTFOLIO

LIST OF FIGURES

FIGURE 01. SMART PILLS MARKET SEGMENTATION
FIGURE 02. TOP INVESTMENT POCKETS IN SMART PILLS MARKET, 2017
FIGURE 03. TOP WINNING STRATEGIES, BY YEAR, 2016-2018*
FIGURE 04. TOP WINNING STRATEGIES, BY DEVELOPMENT, 2016-2018* (%)
FIGURE 05. TOP WINNING STRATEGIES, BY COMPANY, 2016-2018*
FIGURE 06. HIGH BARGAINING POWER OF SUPPLIERS
FIGURE 07. MODERATE BARGAINING POWER OF BUYERS
FIGURE 08. LOW THREAT OF SUBSTITUTION
FIGURE 09. HIGH THREAT OF NEW ENTRANT
FIGURE 10. HIGH COMPETITIVE RIVALRY
FIGURE 11. MARKET SHARE ANALYSIS, 2017
FIGURE 12. GLOBAL SMART PILLS MARKET: RESTRAINTS, DRIVERS, AND OPPORTUNITY
FIGURE 13. COMPARATIVE SHARE ANALYSIS OF SMART PILLS MARKET FOR CAPSULE ENDOSCOPY, BY COUNTRY, 2017 & 2025 (%)
FIGURE 14. COMPARATIVE SHARE ANALYSIS OF SMART PILLS MARKET FOR DISPOSABLES & REAGENTS, BY COUNTRY, 2017 & 2025 (%)
FIGURE 15. COMPARATIVE SHARE ANALYSIS OF SMART PILLS MARKET FOR PATIENT MONITORING, BY COUNTRY, 2017 & 2025 (%)
FIGURE 16. COMPARATIVE SHARE ANALYSIS OF SMART PILLS MARKET, FOR ESOPHAGUS BY COUNTRY, 2017 & 2025 (%)
FIGURE 17. COMPARATIVE SHARE ANALYSIS OF SMART PILLS MARKET, FOR STOMACH, BY COUNTRY, 2017 & 2025 (%)
FIGURE 18. COMPARATIVE SHARE ANALYSIS OF SMART PILLS MARKET, FOR SMALL INTESTINE, BY COUNTRY, 2017 & 2025 (%)
FIGURE 19. COMPARATIVE SHARE ANALYSIS OF SMART PILLS MARKET, FOR LARGE INTESTINE, BY COUNTRY, 2017 & 2025 (%)
FIGURE 20. COMPARATIVE SHARE ANALYSIS OF SMART PILLS MARKET, FOR ESOPHAGUS DISEASES, BY COUNTRY, 2017 & 2025 (%)
FIGURE 21. COMPARATIVE SHARE ANALYSIS OF SMART PILLS MARKET, FOR SMALL BOWEL DISEASES, BY COUNTRY, 2017 & 2025 (%)
FIGURE 22. GLOBAL SMART PILLS MARKET FOR CROHNS DISEASE, 2017-2025 ($MILLION)
FIGURE 23. GLOBAL SMART PILLS MARKET FOR SMALL BOWEL TUMORS, 2017-2025 ($MILLION)
FIGURE 24. GLOBAL SMART PILLS MARKET FOR CELIAC DISEASE, 2017-2025 ($MILLION)
FIGURE 25. GLOBAL SMART PILLS MARKET FOR CELIAC DISEASE, 2017-2025 ($MILLION)
FIGURE 26. COMPARATIVE SHARE ANALYSIS OF SMART PILLS MARKET, FOR COLON DISEASES, BY COUNTRY, 2017 & 2025 (%)
FIGURE 27. COMPARATIVE SHARE ANALYSIS OF SMART PILLS MARKET FOR DIAGNOSTIC CENTRES, BY COUNTRY, 2017 & 2025 (%)
FIGURE 28. COMPARATIVE SHARE ANALYSIS OF SMART PILLS MARKET FOR HOSPITALS & CLINICS, BY COUNTRY, 2017 & 2025 (%)
FIGURE 29. COMPARATIVE SHARE ANALYSIS OF SMART PILLS MARKET FOR OTHERS, BY COUNTRY, 2017 & 2025 (%)
FIGURE 30. INTROMEDIC, 2015-2017 ($MILLION)
FIGURE 31. PHILIPS: NET SALES, 2015-2017 ($MILLION)
FIGURE 32. PHILIPS: REVENUE SHARE BY SEGMENT, 2017 (%)
FIGURE 33. PHILIPS: REVENUE SHARE BY GEOGRAPHY, 2017 (%)
FIGURE 34. MEDTRONIC, 2015-2017 ($MILLION)
FIGURE 35. MEDTRONIC: REVENUE SHARE BY SEGMENT, 2017 (%)
FIGURE 36. MEDTRONIC: REVENUE SHARE BY GEOGRAPHY, 2017 (%)
FIGURE 37. OLYMPUS: REVENUE, 2015-2017 ($MILLION)
FIGURE 38. OLYMPUS: REVENUE SHARE BY SEGMENT, 2017 (%)
FIGURE 39. OLYMPUS: REVENUE SHARE BY GEOGRAPHY, 2017 (%)

 

 

Smart pills are capsule-sized ingestible medical devices that consist of sensors, cameras, patches, and trackers that help in better diagnostics, patient monitoring, as well as targeted drug delivery. Smart pills, being non-invasive can be a potent alternative approach against invasive procedures such as gastrointestinal endoscopy/colonoscopy. The major factors that drive the growth of the global smart pills market are rise in R&D expenditure pertaining to smart pills, increase in per capita expenditure on healthcare in developing economies, and favorable government regulations.

The major factors that contribute to the market growth include increase in geriatric population, rise in gastrointestinal disorders such as GERD, colorectal cancer, and others. In addition, increased use of smart pills in diagnostic centers and hospitals for the diagnosis of the disease significantly drives the growth of the market. Further, smart pills are being considered as a potent alternative to traditional, painful, endoscopic procedures, which also is expected to fuel the market growth.

Moreover, capsule endoscopy accounted for the largest market share in the application segment owing to its increased use in diagnostic procedures for gastrointestinal disorders. Capsule endoscopy is being widely performed to diagnose the aforementioned disease indications and thereby, significantly contributes for the growth of smart pills globally. There have been remarkable advancements as well as some major developments, such as devices with more throughput and accurate results, in this market. Nevertheless, the growth in need of non-invasive devices has increased the demand for innovative technologies along with newer versions of capsule endoscopes.

 

PURCHASE OPTIONS

* Taxes/Fees, If applicable will be
added during checkout. All prices in USD.

Reach out to us

Call us on
( U.S. - Canada toll free )
+1-800-792-5285,    Int'l : +1-503-894-6022
Drop us an email at
help@alliedmarketresearch.com

Send Enquiry
 

Request Sample

Request Customization

Request sample

OR

Purchase Full Report of
Smart Pills Market

  • Online Only
  • $3456
  • Online cloud Access only
  • Restricted Print, copy, paste,download
  • Read Only
  • 20% free customization (Pre-Sale)
  •   Free quartery industry update
  •   Free report update (Within 180 days)
  •   Subscription Model Sign In
  • Data Pack
  • $3840
  • Restricted to one authorized users
  • One print only
  • Available in Excel
  • 20% free customization (Pre-Sale)
  •   Free quartery industry update
  •   Free report update (Within 180 days)
  •   Subscription Model Sign In
  • Single User
  • $5370
  • Restricted to one authorized users
  • One print only
  • Available in Excel & PDF
  • 20% free customization (Pre-Sale)
  •   Free quartery industry update
  •   Free report update (Within 180 days)
  •   Subscription Model Sign In
  • Five User
  • $6450
  • Limited to 5 authorized users
  • Print Upto Five Copies
  • Available in Excel & PDF
  • 20% free customization (Pre-Sale)
  •   Free quartery industry update
  •   Free report update (Within 180 days)
  •   Subscription Model Sign In
  • Enterprise
    License/PDF

  • $8995
  • Unlimited within company/enterprise
  • Unlimited within company/enterprise
  • Available in Excel & PDF
  • 20% free customization (Pre-Sale)
  •   Free quartery industry update
  •   Free report update (Within 180 days)
  •   Subscription Model Sign In

*Taxes/Fees, if applicable will be added during checkout. All prices in USD

 

HAVE QUESTIONS?
SPEAK WITH ANALYST

 
 

FREQUENTLY ASKED
QUESTIONS?

 
 

DID YOU MISS ANYTHING?
DO YOU HAVE SPECIFIC REQUIREMENTS?

 
 
 

Why Allied Market Research

 

Infallible Methodology

To ensure high level data integrity, accurate analysis and impeccable forecasts

Analyst Support

For complete satisfaction

Customization

On-demand customization of scope of the report to exactly meet your needs

TARGETED MARKET VIEW

Targeted market view to provide pertinent information and save time of readers

 
 

Featured Reports

 
 

Featured Readings

 

Get Fresh content delivered

Get insights on topics that are crucial for your business. Stay abreast of your interest areas.

 
Get Industry Data Alerts
 

Access reports on all emerging
market of Life Sciences on Knowledge Tree Platform
Free Demo